home / stock / xrtxf / xrtxf news

XRTXF News and Press, XORTX Therapeutics Inc From 01/19/23

Stock Information
Company Name: XORTX Therapeutics Inc
Stock Symbol: XRTXF
Market: OTC
Website: xortx.com
Menu
XRTXF XRTXF Quote XRTXF Short XRTXF News XRTXF Articles XRTXF Message Board
Get XRTXF Alerts

News, Short Squeeze, Breakout and More Instantly...
XRTXF - XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

CALGARY, Alberta, Jan. 19, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney diseas...
XRTXF - XORTX Therapeutics Announces Closing of US$12 Million Public Offering

CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, today announced t...

XRTXF - XORTX Announces Results from Mount Sinai's COVID-19 Clinical Study

CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to ann...

XRTXF - XORTX to Present at the LD Micro Main Event

CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announces its par...
XRTXF - XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing

CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announces the pri...

XRTXF - XORTX Therapeutics Announces Share Consolidation

CALGARY, Alberta, Sept. 20, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, announces that f...

XRTXF - XORTX Therapeutics Reports Special Meeting Results

CALGARY, Alberta, Sept. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to ...
XRTXF - XORTX Therapeutics Calls Special Meeting of Shareholders

CALGARY, Alberta, Aug. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that t...

XRTXF - XORTX Therapeutics names Amar Keshri CFO

XORTX Therapeutics (XRTXF) announces that Amar Keshri will replace James Fairbairn as the company's chief financial officer.Amar was most recently involved in providing consulting services to US based start-ups in the process of going public.He will work closely with CEO Allen ...

XRTXF - XORTX Therapeutics Strengthens Executive Team

CALGARY, Alberta, July 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that M...
Previous 10 Next 10